
Misook Yu
Supervisory Patent Examiner (ID: 13848, Phone: (571)272-0839 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1641 |
| Total Applications | 878 |
| Issued Applications | 268 |
| Pending Applications | 204 |
| Abandoned Applications | 408 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6797469
[patent_doc_number] => 20030176343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Diagnostics and therapeutic uses of topors'
[patent_app_type] => new
[patent_app_number] => 10/339924
[patent_app_country] => US
[patent_app_date] => 2003-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 8139
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176343.pdf
[firstpage_image] =>[orig_patent_app_number] => 10339924
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/339924 | Diagnostics and therapeutic uses of topors | Jan 8, 2003 | Abandoned |
Array
(
[id] => 6846787
[patent_doc_number] => 20030165954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Cancer profiles'
[patent_app_type] => new
[patent_app_number] => 10/339533
[patent_app_country] => US
[patent_app_date] => 2003-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29198
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20030165954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10339533
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/339533 | Cancer profiles | Jan 8, 2003 | Abandoned |
Array
(
[id] => 563996
[patent_doc_number] => 07465553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-16
[patent_title] => 'Psoriasin expression by breast epithelial cells'
[patent_app_type] => utility
[patent_app_number] => 10/331200
[patent_app_country] => US
[patent_app_date] => 2002-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 11242
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/465/07465553.pdf
[firstpage_image] =>[orig_patent_app_number] => 10331200
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/331200 | Psoriasin expression by breast epithelial cells | Dec 29, 2002 | Issued |
Array
(
[id] => 7374709
[patent_doc_number] => 20040093621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Antibody composition which specifically binds to CD20'
[patent_app_type] => new
[patent_app_number] => 10/327663
[patent_app_country] => US
[patent_app_date] => 2002-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 48568
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20040093621.pdf
[firstpage_image] =>[orig_patent_app_number] => 10327663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/327663 | Antibody composition which specifically binds to CD20 | Dec 23, 2002 | Abandoned |
Array
(
[id] => 6740163
[patent_doc_number] => 20030157532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Method for identifying compounds altering higher-order chromatin-dependent chromosome stability'
[patent_app_type] => new
[patent_app_number] => 10/323968
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 20675
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10323968
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/323968 | Method for identifying compounds altering higher-order chromatin-dependent chromosome stability | Dec 19, 2002 | Abandoned |
Array
(
[id] => 7429706
[patent_doc_number] => 20040001842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors'
[patent_app_type] => new
[patent_app_number] => 10/323692
[patent_app_country] => US
[patent_app_date] => 2002-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16666
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20040001842.pdf
[firstpage_image] =>[orig_patent_app_number] => 10323692
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/323692 | Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors | Dec 18, 2002 | Abandoned |
Array
(
[id] => 6769505
[patent_doc_number] => 20030215445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Methods and compositions for inhibiting the growth of hematopoietic malignant cells'
[patent_app_type] => new
[patent_app_number] => 10/321587
[patent_app_country] => US
[patent_app_date] => 2002-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 18018
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215445.pdf
[firstpage_image] =>[orig_patent_app_number] => 10321587
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/321587 | Methods and compositions for inhibiting the growth of hematopoietic malignant cells | Dec 17, 2002 | Abandoned |
Array
(
[id] => 7469146
[patent_doc_number] => 20040102407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer'
[patent_app_type] => new
[patent_app_number] => 10/313972
[patent_app_country] => US
[patent_app_date] => 2002-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 118338
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102407.pdf
[firstpage_image] =>[orig_patent_app_number] => 10313972
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/313972 | Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer | Dec 5, 2002 | Issued |
Array
(
[id] => 6778158
[patent_doc_number] => 20030049239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Therapeutic compositions and methods for treating tumors'
[patent_app_type] => new
[patent_app_number] => 10/301328
[patent_app_country] => US
[patent_app_date] => 2002-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7306
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10301328
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/301328 | Therapeutic compositions and methods for treating tumors | Nov 20, 2002 | Abandoned |
Array
(
[id] => 243180
[patent_doc_number] => 07588914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Bacterial Bcl-2 domain-containing polypeptides, encoding nucleic acid molecules, and related methods'
[patent_app_type] => utility
[patent_app_number] => 10/294445
[patent_app_country] => US
[patent_app_date] => 2002-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14960
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/588/07588914.pdf
[firstpage_image] =>[orig_patent_app_number] => 10294445
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/294445 | Bacterial Bcl-2 domain-containing polypeptides, encoding nucleic acid molecules, and related methods | Nov 12, 2002 | Issued |
Array
(
[id] => 232913
[patent_doc_number] => 07598340
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-06
[patent_title] => 'Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses'
[patent_app_type] => utility
[patent_app_number] => 10/292541
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10777
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/598/07598340.pdf
[firstpage_image] =>[orig_patent_app_number] => 10292541
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/292541 | Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses | Nov 11, 2002 | Issued |
Array
(
[id] => 281821
[patent_doc_number] => 07553821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-30
[patent_title] => 'Methods for selectively modulating survivin apoptosis pathways'
[patent_app_type] => utility
[patent_app_number] => 10/291607
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 36
[patent_no_of_words] => 19948
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/553/07553821.pdf
[firstpage_image] =>[orig_patent_app_number] => 10291607
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/291607 | Methods for selectively modulating survivin apoptosis pathways | Nov 11, 2002 | Issued |
Array
(
[id] => 6730185
[patent_doc_number] => 20030186375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Nuclear myosin I beta with a 16 amino acid N-terminal extension'
[patent_app_type] => new
[patent_app_number] => 10/287216
[patent_app_country] => US
[patent_app_date] => 2002-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7536
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186375.pdf
[firstpage_image] =>[orig_patent_app_number] => 10287216
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/287216 | Nuclear myosin I beta with a 16 amino acid N-terminal extension | Nov 3, 2002 | Abandoned |
Array
(
[id] => 620003
[patent_doc_number] => 07141435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-28
[patent_title] => 'Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP'
[patent_app_type] => utility
[patent_app_number] => 10/285408
[patent_app_country] => US
[patent_app_date] => 2002-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5870
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/141/07141435.pdf
[firstpage_image] =>[orig_patent_app_number] => 10285408
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/285408 | Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP | Oct 31, 2002 | Issued |
Array
(
[id] => 7024947
[patent_doc_number] => 20050019341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Tumor antigen'
[patent_app_type] => utility
[patent_app_number] => 10/494069
[patent_app_country] => US
[patent_app_date] => 2002-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16883
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019341.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494069
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494069 | Tumor antigen | Oct 28, 2002 | Abandoned |
Array
(
[id] => 672037
[patent_doc_number] => 07091047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-15
[patent_title] => 'Methods and kits for diagnosing tumorigenicity'
[patent_app_type] => utility
[patent_app_number] => 10/281160
[patent_app_country] => US
[patent_app_date] => 2002-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 14079
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/091/07091047.pdf
[firstpage_image] =>[orig_patent_app_number] => 10281160
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/281160 | Methods and kits for diagnosing tumorigenicity | Oct 27, 2002 | Issued |
Array
(
[id] => 6856130
[patent_doc_number] => 20030129631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Gene family with transformation modulating activity'
[patent_app_type] => new
[patent_app_number] => 10/273334
[patent_app_country] => US
[patent_app_date] => 2002-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 16240
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129631.pdf
[firstpage_image] =>[orig_patent_app_number] => 10273334
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/273334 | Gene family with transformation modulating activity | Oct 17, 2002 | Abandoned |
Array
(
[id] => 6856128
[patent_doc_number] => 20030129629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Methods and compositions for the identification, assessment, prevention, and therapy of human cancers'
[patent_app_type] => new
[patent_app_number] => 10/272111
[patent_app_country] => US
[patent_app_date] => 2002-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50320
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129629.pdf
[firstpage_image] =>[orig_patent_app_number] => 10272111
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/272111 | Methods and compositions for the identification, assessment, prevention, and therapy of human cancers | Oct 15, 2002 | Abandoned |
Array
(
[id] => 7463070
[patent_doc_number] => 20040053228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Apoptosis inhibitory polypeptides, gene and polynucleotide encoding it and compositions containing the same'
[patent_app_type] => new
[patent_app_number] => 10/148953
[patent_app_country] => US
[patent_app_date] => 2002-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6808
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053228.pdf
[firstpage_image] =>[orig_patent_app_number] => 10148953
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/148953 | Apoptosis inhibitory polypeptides, gene and polynucleotide encoding it and compositions containing the same | Oct 15, 2002 | Abandoned |
Array
(
[id] => 536500
[patent_doc_number] => 07173112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-06
[patent_title] => 'Antibody to GALP and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/490917
[patent_app_country] => US
[patent_app_date] => 2002-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 14618
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/173/07173112.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490917
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490917 | Antibody to GALP and uses thereof | Sep 24, 2002 | Issued |